Aura Biosciences's total current liabilities is $21M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2026), AURA shows a total current liabilities of $21M. That compares with $19M in the prior-year period — up 13.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, AURA's total current liabilities is now $21M (was $19M) — a 13.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Aura Biosciences is outperforming or lagging.
Tracking AURA's total current liabilities over time shows whether Aura Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $19M in the prior-year period — up 13.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total current liabilities page, Stockcircle has Aura Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total current liabilities (currently $21M) with ownership activity and broader fundamentals.